Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Last Updated: November 28, 2021

DrugPatentWatch Database Preview

Litigation Details for Bial - Portela & CA, S.A. v. Torrent Pharmaceuticals Ltd. (D. Del. 2018)

Email this page to a colleague

« Back to Dashboard

Bial - Portela & CA, S.A. v. Torrent Pharmaceuticals Ltd. (D. Del. 2018)

Docket ⤷  Free Forever Trial Date Filed 2018-02-15
Court District Court, D. Delaware Date Terminated 2021-11-17
Cause 35:271 Patent Infringement Assigned To Colm Felix Connolly
Jury Demand Defendant Referred To Christopher J. Burke
Parties BIAL - HOLDING, S.A.
Patents 8,372,431; 9,206,135; 9,566,244; 9,643,929; 9,750,747; 9,763,954
Attorneys Oren D. Langer
Firms Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in Bial - Portela & CA, S.A. v. Torrent Pharmaceuticals Ltd.
The small molecule drug covered by the patents cited in this case is ⤷  Free Forever Trial .

Details for Bial - Portela & CA, S.A. v. Torrent Pharmaceuticals Ltd. (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
2018-02-15 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,372,431; 9,206,135; 9,566,244…2018 18 November 2021 1:18-cv-00279 Patent - Abbreviated New Drug Application(ANDA) Defendant External link to document
2019-10-17 63 Order - -Memorandum and Order found in six patents asserted in this case: U.S. Patent Nos. 5,753,646 ("the #646 patent"), 8,…the #431 patent"), 9,206,135 ("the #135 patent"), 9,566,244 ("the #244 patent")…oxcarbazepine." #135 patent at 1: 18-22; #929 patent at 1:20-24. The title of both patents is "Asymmetric…manufacturing purposes." #135 patent at 2:27-32; #929 patent at 2:10-35. The patent's solution to the …,643,929 ("the #929 patent"), and 9,750,747 ("the #747 patent). Oral argument regarding External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.